Equity Overview
Price & Market Data
Price: $4.95
Daily Change: +$0.11 / 2.22%
Daily Range: $4.56 - $5.08
Market Cap: $94,182,656
Daily Volume: 22,049
Performance Metrics
1 Week: 14.85%
1 Month: 10.49%
3 Months: -17.22%
6 Months: -79.80%
1 Year: -79.80%
YTD: -59.12%
Company Details
Employees: 4
Sector: Health technology
Industry: Biotechnology
Country:
Details
NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in clinical trials for the treatment of glioblastoma; and NEO212, a covalently conjugated molecule combining chemotherapeutic drug temozolomide with perillyl alcohol that is in Phase I/II clinical trials for its oral administration to patients with primary and secondary brain tumors. The company was formerly known as NAS-ONC, Inc. and changed its name to NeOnc Technologies Holdings, Inc. in 2009. NeOnc Technologies Holdings, Inc. was incorporated in 2005 and is based in Calabasas, California.